cyclophosphamide

Open Access
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction
YUTARO KUBOTA, QINGHONG HAN, NORIYUKI MASAKI, CHIHIRO HOZUMI, KAZUYUKI HAMADA, YUSUKE AOKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research December 2022, 42 (12) 5819-5823; DOI: https://doi.org/10.21873/anticanres.16089
You have access
Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer
MISATO OGINO, TAKAAKI FUJII, YUKIO KOIBUCHI, YUKO NAKAZAWA, DAISUKE TAKATA and KEN SHIRABE

Anticancer Research August 2021, 41 (8) 3899-3904; DOI: https://doi.org/10.21873/anticanres.15185
You have access
Experimental Comparison of the In Vivo Efficacy of Two Novel Anticancer Therapies
VERA S. RUZANOVA, ANASTASIA S. PROSKURINA, GENRIKH S. RITTER, YAROSLAV R. EFREMOV, VALERIY P. NIKOLIN, NELLY A. POPOVA, VASILIY A. NAPRIMEROV, EVGENIA V. DOLGOVA, EKATERINA A. POTTER, SVETLANA S. KIRIKOVICH, EVGENIY V. LEVITES, ZAKHAR S. MUSTAFIN, SERGEY A. LASHIN, EKATERINA A. BURAKOVA, DMITRY A. STETSENKO, ALEXANDR A. OSTANIN, ELENA R. CHERNYKH and SERGEY S. BOGACHEV

Anticancer Research July 2021, 41 (7) 3371-3387; DOI: https://doi.org/10.21873/anticanres.15125
You have access
Successful Stabilization of Symptomatic Bone Marrow Metastasis Two Times in a Breast Cancer Patient
HIDEKO AKAGI, AKIHIKO SHIMADA, KENKO CHIN and HIDEHARU DOMOTO

Anticancer Research June 2021, 41 (6) 3139-3144; DOI: https://doi.org/10.21873/anticanres.15099
You have access
Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma
POLINA E. KISARETOVA, SVETLANA S. KIRIKOVICH, GENRICH S. RITTER, YAROSLAV R. EFREMOV, OLEG S. TARANOV, TATYANA D. DUBATOLOVA, ANASTASIA S. PROSKURINA, EKATERINA A. POTTER, EVGENIA V. DOLGOVA, SERGEY V. SIDOROV, ALEKSANDR A. OSTANIN, ELENA R. CHERNYCH and SERGEY S. BOGACHEV

Anticancer Research February 2020, 40 (2) 795-805; DOI: https://doi.org/10.21873/anticanres.14011
You have access
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI and ATSUSHI FUKUUCHI

Anticancer Research December 2019, 39 (12) 6903-6907; DOI: https://doi.org/10.21873/anticanres.13910
You have access
Memory Antitumor T-Cells Resist Inhibition by Immune Suppressor Cells
YANHUA GAO, PATRICIA WHITAKER-DOWLING and IRA BERGMAN

Anticancer Research September 2015, 35 (9) 4593-4597;
You have access
Long-term Control in a Patient with Refractory Multiple Myeloma by Oral Cyclophosphamide and Dexamethasone
NORMANN STEINER, DAVID NACHBAUR, PAUL KÖNIG, WOLFGANG WILLENBACHER and EBERHARD GUNSILIUS

Anticancer Research April 2015, 35 (4) 2165-2168;
You have access
Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-β Tubulin and Non-basal Subtype
KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, KUMIKO KITA, KAZUTAKA NARUI, SADAYOSHI SUGAE, DAISUKE SHIMIZU, MIKIKO TANABE, TAKESHI SASAKI, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO

Anticancer Research February 2015, 35 (2) 907-912;
You have access
An Improved and Versatile Immunosuppression Protocol for the Development of Tumor Xenograft in Mice
MEHUL JIVRAJANI, MUHAMMAD VASEEM SHAIKH, NEETA SHRIVASTAVA and MANISH NIVSARKAR

Anticancer Research December 2014, 34 (12) 7177-7183;

Main menu

User menu

Search

cyclophosphamide

Pages